SCHEMBL31153419

SCHEMBL31153419

CNC(=O)c1ccc2c(n1)c(N(C)c1ccc(Cl)nc1)nn2C1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 9/20 0.42
▸ BRD4 O60885 3/20 0.37
▸ TRIM24 O15164 1/20 0.37
▸ BRD1 O95696 1/20 0.37
▸ TAF1 P21675 1/20 0.37
▸ BRD2 P25440 1/20 0.37
▸ BRPF1 P55201 1/20 0.37
▸ EP300 Q09472 1/20 0.37
▸ BRD3 Q15059 1/20 0.37
▸ BRDT Q58F21 1/20 0.37
▸ PBRM1 Q86U86 1/20 0.37
▸ TAF1L Q8IZX4 1/20 0.37
▸ BRD9 Q9H8M2 1/20 0.37
▸ BRD7 Q9NPI1 1/20 0.37
▸ BRWD1 Q9NSI6 1/20 0.37
▸ BAZ2B Q9UIF8 1/20 0.37
▸ BAZ2A Q9UIF9 1/20 0.37
▸ BRPF3 Q9ULD4 1/20 0.37
▸ PDE4D Q08499 1/20 0.36
▸ NR3C1 P04150 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31153425 0.90 PDE4D (0.35) CREBBPPDE4DNR3C1SPR
SCHEMBL31153407 0.90 TUBB4A (0.38) CREBBPPDE4DNR3C1SPRIRAK4
SCHEMBL31153553 0.79 CFTR (0.35) CREBBPBRD4NR3C1
SCHEMBL31153458 0.79 TUBB4A (0.38) CREBBPBRD4PDE4DNR3C1IRAK4
SCHEMBL19657665 0.76 CREBBP (0.48) CREBBPBRD4TRIM24BRD1TAF1
SCHEMBL22822778 0.74 CREBBP (0.48) CREBBPBRD4TRIM24BRD1TAF1
SCHEMBL31153490 0.73 NR3C1 (0.34) CREBBPPDE4DNR3C1IRAK4
SCHEMBL31153418 0.69 CREBBP (0.47) CREBBPBRD4
SCHEMBL29704418 0.63 PTGER4 (0.40) CREBBPBRD4IRAK4
SCHEMBL19657727 0.63 PTGER4 (0.40) CREBBPBRD4IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 — — WO disclosed
Send feedback